In this article, we will look at the 12 Cheap NASDAQ Stocks to Buy Now.
On December 3, Michael Kantrowitz, Chief Investment Strategist at Piper Sandler, appeared on CNBC television to discuss the market outlook for 2026. He believes that the backdrop is strong for the stock market heading into 2026. Kantrowitz highlighted that the market has been focused a lot on interest rates, similar to the 2022-23 market, where inflation was in the spotlight. Currently, the softer labor market has emerged as a new concern. Kantrowitz noted that investors need to look further back in history to be able to better understand the market today.
He suggests that the current market set-up points towards a softer labor market, paving the way for lower interest rates. Kantrowitz added that examples from recent times suggest that the stock market performance has an inverse relation with interest rates. Therefore, lower interest rates induced by a weaker labor market will help the stock market go even higher in 2026.
Kantrowitz added that higher interest rates have been one of the key factors preventing the broadening of the market. He expects 2026 to be a year of broadening out, favored by a lower interest rate environment, which will help underperforming sectors, including manufacturing, transportation, and housing, to rebound.
With that, let’s take a look at the 12 Cheap NASDAQ Stocks to Buy Now.
Our Methodology
To compile the list of 12 Cheap NASDAQ Stocks to Buy Now, we used the Finviz stock screener, Seeking Alpha, and Insider Monkey’s Q3 2025 hedge funds database. Using the screener, we aggregated a list of stocks trading on the NASDAQ stock exchange with a forward price-to-earnings ratio below 15. Next, we sorted the list by market capitalization and cross-checked the P/E ratios from Seeking Alpha. Lastly, we ranked the stocks in ascending order of the number of hedge fund holders. Please note that the data was recorded on Friday, December 5, 2025.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 427.7% since May 2014, beating its benchmark by 264 percentage points (see more details here).
12 Cheap NASDAQ Stocks to Buy Now
12. Sanofi (NASDAQ:SNY)
Forward P/E Ratio: 10.7
Number of Hedge Fund Holders: 32
Sanofi (NASDAQ:SNY) is one of the Cheap NASDAQ Stocks to Buy Now. On December 4, Sanofi (NASDAQ:SNY) announced the completion of the Vicebio acquisition. Vicebio is a clinical-stage biotechnology company focused on developing transformative multi-pathogen vaccines for respiratory viral infections.
Management noted that this strategic acquisition brings Vicebio’s early-stage vaccine candidate for respiratory syncytial virus and human metapneumovirus under Sanofi’s portfolio. Moreover, the company also noted that the acquisition will allow it to enhance vaccine design and development using Vicebio’s Molecular Clamp technology.
Earlier on November 25, Sanofi (NASDAQ:SNY) announced that its jointly developed program with Regeneron called Dupilumab was approved by the European Commission to treat moderate-to-severe chronic spontaneous urticaria in adult and adolescent patients 12 years and above. Management noted that Dupilumab can be used as a first-line targeted treatment option.
The EU approval was based on positive results from the Phase 3 study, which showed Dupilumab reduced symptoms at 24 weeks compared to the placebo. The addressable market in the EU is significant, as there are over 270,000 adults and adolescents aged 12 years and older with chronic spontaneous urticaria.
Sanofi (NASDAQ:SNY) researches, produces, and distributes pharmaceutical products. The company’s operations are divided into the Pharmaceuticals, Consumer Healthcare, and Vaccines segments.
11. Trip.com Group Limited (NASDAQ:TCOM)
Forward P/E Ratio: 11.01
Number of Hedge Fund Holders: 37
Trip.com Group Limited (NASDAQ:TCOM) is one of the Cheap NASDAQ Stocks to Buy Now. Wall Street has a positive outlook on Trip.com Group Limited (NASDAQ:TCOM) since the company topped estimates during its fiscal Q3 2025 earnings release on November 17.
On November 26, Yang Liu, CFA from Morgan Stanley, reiterated a Buy rating on the stock with a price target of $86. Earlier on November 20, Joyce Ju from Bank of America Securities raised the firm’s price target from $83 to $85, while reiterating a Buy rating on the stock.
Trip.com Group Limited (NASDAQ:TCOM) during the fiscal Q3 grew its revenue by 17.64% year-over-year to $2.58 billion, surpassing estimates by $18.41 million. Moreover, the EPS of $3.88 also topped estimates by $2.75. The performance was mainly driven by strong cross-border travel momentum. Management noted the overall bookings on its international OTA platform grew by 60% year-over-year, whereas the inbound travel bookings increased by more than 100% during the same time.
Joyce Ju from Bank of America Securities expects Trip.com Group Limited (NASDAQ:TCOM) to grow its international revenue by around 50% to 60% during Q4. He anticipates the international segment will represent a high teen percentage of the total revenue.
Trip.com Group Limited (NASDAQ:TCOM) provides end-to-end solutions for the corporate travel, lodging, tour, and transportation sectors.
